Form 8-K - Current report:
SEC Accession No. 0001564590-21-061212
Filing Date
2021-12-27
Accepted
2021-12-27 06:31:16
Documents
12
Period of Report
2021-12-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-8k_20211227.htm   iXBRL 8-K 28897
  Complete submission text file 0001564590-21-061212.txt   152447

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20211227.xsd EX-101.SCH 5701
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20211227_lab.xml EX-101.LAB 18571
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20211227_pre.xml EX-101.PRE 11047
6 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20211227_htm.xml XML 3408
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 211518885
SIC: 2834 Pharmaceutical Preparations